Riskpilot← Back to searchSign inGet full accessNG HELSE OG VELVÆRE AS
ASActiveOrg 928991776Karenslyst Allé 12, 0278 OsloOther business support service activities n.e.c. · NACE 8299Est. 20220 employees
Revenue 2024
NOK 0
EBITDA margin
—
+20% vs 2023
Equity ratio
99.8%
Financial strength
Net profit 2024
NOK -86K
+29% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -153K | +20% |
| Net profit | NOK -86K | +29% |
| Total assets | NOK 1M | -1% |
| Equity | NOK 1M | +0% |
| Employees | 0 | — |
Legal name
NG HELSE OG VELVÆRE AS
Org number
928991776
Legal form
Aksjeselskap
NACE code
8299 · Other business support service activities n.e.c.
Founded
26. mars 2022
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskapets styre består av 2 til 5 styremedlemmer etter generalforsamlingens nærmere beslutning. Selskapets firma tegnes av styrets leder og ett styremedlem i fellesskap eller to styremedlemmer i fellesskap. Styret kan tildele prokura.
Company purpose
Utvikle, forvalte og administrere konsepter innen helse og velvære, herunder vedta overliggende styringsdokument for ovennevnte konsepter. Selskapets formål er videre å kontrollere og følge opp gjeldene mål og retningslinjer nedfelt i overliggende styringsdokument for konseptene, samt alt som står i forbindelse med dette. Herunder inngår investeringer i aksjer og andre selskaper i den grad dette inngår i realisering av ovennevnte formål.
Address
Karenslyst Allé 12, 0278 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 |
| EBITDA | −10 | −191 | −153 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −10 | −191 | −153 |
| Net financials | 18 | 36 | 43 |
| Profit before tax | 8 | −155 | −110 |
| Tax | 2 | −34 | −24 |
| Net profit | 6 | −121 | −86 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 1 008 | 1 014 | 1 008 |
| Equity | 1 006 | 1 006 | 1 006 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 2 | 9 | 2 |
| Total debt | 2 | 9 | 2 |
EBITDA margin
-15341200.0%
This company
15.8%
Market median
-97096303% vs market
20222024
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20222024
Return on equity
-8.6%
This company
18.4%
Market median
-147% vs market
20222024
Net profit margin
-8606800.0%
This company
8.1%
Market median
-106256890% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Joh Johannson Handel AsJoh Johannson Handel Ii AsNorgesgruppen Asa
NG HELSE OG VELVÆRE AS (this company)Board members of NG HELSE OG VELVÆRE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Spikseth | Chief Executive Officer | 0 companies |
| Finn Torstein Dybvik | Chairman | 0 companies |
| Øyvind Øvreeide Jensen | Board of Directors | 0 companies |
| Mette Lier | Board of Directors | 0 companies |